Nature Biotechnology
- 24, 1230 - 1231 (2006)
doi:10.1038/nbt1006-1230
A sugar switch for anti-inflammatory antibodiesRoy Jefferis
Roy Jefferis is in the Division of Immunity and Infection, The Medical School, University of Birmingham, Vincent Drive, Edgbaston, Birmingham, UK. r.jefferis@bham.ac.uk
The finding that antibody sialylation can suppress inflammation provides new opportunities for drug development.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
